Juraj Slabý

Policies for biosimilar uptake in Europe: An overview

Evelien Moorkens, Arnold G. Vulto, Isabelle Huys et al. · PLoS ONE · 2017 · 346 citations · Full text

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries

Tomasz Bochenek, Vafa Abilova, Ali Alkan et al. · Frontiers in Pharmacology · 2018 · 102 citations · Full text

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Evelien Moorkens, Brian Godman, Isabelle Huys et al. · Frontiers in Pharmacology · 2021 · 67 citations · Full text

The European challenges of funding orphan medicinal products

Márta Szegedi, Tamás Zelei, Francis Arickx et al. · Orphanet Journal of Rare Diseases · 2018 · 62 citations · Full text

Comparison of drug prescribing before and during the <scp>COVID</scp>‐19 pandemic: A cross‐national European study

Iva Selke Krulichová, Gisbert Selke, Marion Bennie et al. · Pharmacoepidemiology and Drug Safety · 2022 · 46 citations · Full text